Nearly 250,000 Containers of Peroxide Recalled Nationwide
Key Points:
- The CDC reports that pertussis, rhinovirus, and parainfluenza viruses are currently circulating at elevated levels nationwide, causing ear, nose, and throat symptoms this summer.
- The FDA announced a recall on June 25 of 11 peroxide earwax removal products due to significantly reduced active ingredient levels, containing only about 10% of the expected carbamide peroxide concentration.
- Approximately 244,432 containers of 6.5% carbamide peroxide products, used to soften earwax, were pulled from the market across multiple brands and nationwide distribution.
- The recall is classified as Class II by the FDA, indicating the products may cause temporary or medically reversible health issues but are unlikely to cause serious adverse effects.
- Consumers should check affected lot numbers and expiration dates across various brands, including CVS Health, Clinere, and others, and avoid using the recalled products.